Euro-Med Laboratories Phil., Inc. (PSE:EURO)

Market Cap	4.19B +30.8%
Revenue (ttm)	6.71B +10.7%
Net Income	393.83M +10.8%
EPS	0.09 +4.1%
Shares Out	4.11B
PE Ratio	11.33
Forward PE	n/a
Dividend	0.07 (6.86%)
Ex-Dividend Date	Nov 13, 2025

Volume	5,000
Average Volume	51,800
Open	1.030
Previous Close	1.020
Day's Range	1.030 - 1.030
52-Week Range	0.720 - 1.100
Beta	0.23
RSI	49.99
Earnings Date	Apr 16, 2026

About PSE:EURO

Euro-Med Laboratories Phil., Inc. manufactures and sells various pharmaceutical products in the Philippines and internationally. It manufactures and distributes large and small volume parenterals that are used as solvents for other drugs; sterile water for injection; and other solutions for ophthalmic, inhalation, irrigation, and dialysis. The company also offers specialty fluids comprising dialysis solutions for the treatment of acute or chronic renal failure; hemodialysis solution, a concentrated solution of electrolytes in water for injectio...

• Industry: Pharmaceuticals
• Sector: Healthcare
• Founded: 1988
• Employees: 1,718
• Stock Exchange: Philippine Stock Exchange
• Ticker Symbol: EURO

Financial Performance

In 2024, PSE:EURO's revenue was 5.80 billion, an increase of 10.11% compared to the previous year's 5.26 billion. Earnings were 337.68 million, an increase of 16.46%.